3,301
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Cytotoxicity, dose-enhancement and radiosensitization of glioblastoma cells with rare earth nanoparticles

, , , , ORCID Icon &
Pages 132-143 | Received 17 Aug 2018, Accepted 23 Oct 2018, Published online: 19 Jan 2019

References

  • Stupp R, Mason WP, van den Bent MJ. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996.
  • Bleeker FE, Molenaar RJ, Leenstra S. Recent advances in the molecular understanding of glioblastoma. J Neurooncol. 2012;108:11–27.
  • Young RM, Jamshidi A, Davis G, et al. Current trends in the surgical management and treatment of adult glioblastoma. Ann Transl Med. 2015;3:121.
  • Brastianos PK, Nayyar N, Rosebrock D. Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens. Precis Oncol. 2017;1:33.
  • Rao KS, Reddy MK, Horning JL, et al. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials. 2008;29:4429–4438.
  • Shilo M, Motiei M, Hana P, et al. Transport of nanoparticles through the blood–brain barrier for imaging and therapeutic applications. Nanoscale. 2014;6:2146–2152.
  • Le Duc G, Miladi I, Alric C. Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. ACS Nano. 2011;5:9566–9574.
  • Ji Y, Xiao B, Wang Z, et al. The suppression effect of light rare earth elements on proliferation of two cancer cell lines. Biomed Environ Sci. 2000;13:287–292.
  • Shi P, Huang Z. Proteomic detection of changes in protein synthesis induced by lanthanum in BGC-823 human gastric cancer cells. Biometals. 2005;18:89–95.
  • An Y, Li R, Wang K. Effects of rare earth elements on proliferation of Human Hepatoma Cell SMMC-7721. J Chinese Rare Earth Soc. 2005;23:105–108.
  • Liu H, Yang X, Wang K. Effects of lanthanide ions (La3+, Gd3+ and Yb3+) on growth of human normal liver line 7701 and human cervical carcinoma and the effect of cell apoptosis induced by lanthanide. J Chinese Rare Earth Soc. 2006;24:484–488.
  • Man N, Yu L, Yu S-H, et al. Rare earth oxide nanocrystals as a new class of autophagy inducers. Autophagy. 2010;6:310–311.
  • Carr DH, Brown J, Bydder GM, et al. Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients. AJR Am J Roentgenol. 1984;143:215–224.
  • Kobayashi K, Usami N, Porcel E, et al. Enhancement of radiation effect by heavy elements. Mutat Res. 2010;704:123–131.
  • Assanga SB, Gil SAA, Lewis LL, et al. Cell growth curves for different cell lines and their relationship with biological activities. Int J Biotechnol Mol Biol Res. 2013;4:60–70.
  • Badie B, Goh CS, Klaver J, et al. Combined radiation and p53 gene therapy of malignant glioma cells. Cancer Gene Ther. 1999;6:155–162.
  • Lan T, Zhao Z, Qu Y, et al. Targeting hyperactivated DNA-PKcs by KU0060648 inhibits glioma progression and enhances temozolomide therapy via suppression of AKT signaling. Oncotarget. 2016;7:55555–55571.
  • Chen Y, Yang L, Feng C, et al. Nano neodymium oxide induces massive vacuolization and autophagic cell death in non-small cell lung cancer NCI-H460 cells. Biochem Biophys Res Commun. 2005;337:52–60.
  • Biederbick A, Kern HF, Elsässer HP. Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol. 1995;66:3–14.
  • Pałasz A, Czekaj P. Toxicological and cytophysiological aspects of lanthanides action. Acta Biochim Pol. 2000;47:1107–1114.
  • Sato T, Hashizume M, Hotta Y, et al. Morphology and proliferation of B16 melanoma cells in the presence of lanthanoid and Al3+ ions. Biometals. 1998;11:107–112.
  • Dai Y, Li J, Li J, et al. Effects of rare earth compounds on growth and apoptosis of leukemic cell lines. In Vitro Cell Dev Biol Anim. 2002;38:373–375.
  • Mowat P, Mignot A, Rima W, et al. In vitro radiosensitizing effects of ultrasmall gadolinium based particles on tumour cells 2011. J Nanosci Nanotechnol. 2011;11:7833. 9
  • Li R, Ji Z, Chang CH, et al. Surface interactions with compartmentalized cellular phosphates explain rare earth oxide nanoparticle hazard and provide opportunities for safer design. ACS Nano. 2014;8:1771–1783.
  • Su X, Zheng X, Ni J. Lanthanum citrate induces anoikis of Hela cells. Cancer Lett. 2009;285:200–209.
  • Portess D, Bauer G, Hill MA, et al. Low dose irradiation of nontransformed cells stimulates the selective removal of precancerous cells via intercellular induction of apoptosis. Cancer Res. 2007;67:1246–1251.
  • Azzam EI, Jay-Gerin J-P, Pain D. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 2012;327:48–60.
  • Briggs A, Corde S, Oktaria S, et al. Cerium oxide nanoparticles: influence of the high-Z component revealed on radioresistant 9L cell survival under X-ray irradiation. Nanomedicine. 2013;9:1098–1105.
  • Hill MA. The variation in biological effectiveness of X-rays and gamma rays with energy. Radiat Prot Dosimetry. 2004;112:471–481.
  • Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8:579–591.
  • Butterworth KT, McMahon SJ, Taggart LE, et al. Radiosensitization by gold nanoparticles: effective at megavoltage energies and potential role of oxidative stress. Transl Cancer Res. 2013;2:269–279.
  • Townley HE. Applications of the rare earth elements in cancer imaging and therapy. Cnano. 2013;9:686–691.
  • Allalunis-Turner MJ, Zia PK, Barron GM, et al. Radiation-induced DNA damage and repair in cells of a radiosensitive human malignant glioma cell line. Radiat Res.1995;144:288–293.
  • Prithivirajsingh S, Story M, Bergh S, et al. Accumulation of common mitochondrial DNA deletion induced by ionizing radiation. FEBS Lett. 2004;571:227–232.
  • Hall J, Iype R, Senra J, et al. Investigation of radiosensitivity gene signatures in cancer cell lines. PLoS ONE. 2014;9(1):e86329.
  • Ader I, Delmas C, Skuli N, et al. Preclinical evidence that SSR128129E–a novel small-molecule multi-fibroblast growth factor receptor blocker–radiosensitises human glioblastoma. Eur J Cancer. 2014;50:2351–2359.